Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pixium Vision S.A.
DescriptionFirst generation intelligent retinal implant system with a 49-electrode epi-retinal array
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices
Latest Stage of DevelopmentPilot
Standard Indication Ophthalmic (unspecified)
Indication DetailsRestore vision in patients with retinal dystrophy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today